Related Experiment Video

Updated: Aug 15, 2026

The Rabbit Model of Accelerated Atherosclerosis: A Methodological Perspective of the Iliac Artery Balloon Injury
09:14

The Rabbit Model of Accelerated Atherosclerosis: A Methodological Perspective of the Iliac Artery Balloon Injury

Published on: October 3, 2017

"Jnking" atherosclerosis

G Sumara1, M Belwal, R Ricci

  • 1Institute of Cell Biology, ETH Zürich (Hönggerberg), Schafmattstrasse 18, 8093, Zürich, Switzerland.

Cellular and Molecular Life Sciences : CMLS
|October 19, 2005
PubMed

Insights

C-jun N-terminal kinase (JNK) plays a role in many diseases. JNK2 specifically promotes foam cell formation, suggesting JNK2 inhibition may treat atherosclerosis.

Area of Science:

  • Molecular Biology
  • Immunology
  • Cardiovascular Research

Background:

  • The C-jun N-terminal kinase (JNK) family (JNK1, JNK2, JNK3) is implicated in various pathological conditions.
  • JNK's role in atherosclerosis was previously uncertain, with evidence mainly from in vitro studies.
  • Key cellular processes in atherosclerosis, such as endothelial cell activation and smooth muscle cell proliferation, involve JNK.

Purpose of the Study:

  • To review JNK-dependent cellular and molecular mechanisms in atherosclerosis.
  • To highlight the potential of JNK2 inhibition as a therapeutic strategy for atherosclerosis.

Main Methods:

  • Review of existing literature on JNK signaling pathways in atherosclerosis.
  • Analysis of in vitro and in vivo studies investigating JNK's role in atherogenesis.
  • Focus on macrophage-specific JNK2 function in foam cell formation.

Main Results:

  • Macrophage-restricted deletion of JNK2 significantly reduced atherosclerosis in mouse models.
  • JNK2 was identified as a key promoter of scavenger receptor A-mediated foam cell formation.
  • Foam cell formation is a critical early step in atherogenesis.

Conclusions:

  • JNK2 plays a specific and crucial role in promoting atherosclerosis.
  • Targeting JNK2 activity presents a promising therapeutic avenue for attenuating atheroma formation.
  • Further research into JNK-dependent mechanisms could lead to novel treatments for cardiovascular disease.

More Related Videos

Induction of Accelerated Atherosclerosis in Mice: The "Wire-Injury" Model05:35

Induction of Accelerated Atherosclerosis in Mice: The "Wire-Injury" Model

Published on: August 25, 2020

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...